Medical Pharmaceuticals

All the latest pharmaceutical news, including the research and development of new medications and treatments. This section contains releases regarding clinical trials at all stages, FDA approval status and general pharmaceutical research results. Find stories on the release and marketing of new drugs alongside corporate and financial reporting from pharmaceutical companies. Includes stock and shareholder information, annual meetings, board changes and appointments, quarterly reports and new acquisitions and mergers.

Latest

14:44 CST Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

Recently, Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in...

14:33 CST Call for Application for 2025 Tsinghua Amgen Scholars Program

The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to...

10 Dec, 2024, 22:31 CST Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global...

10 Dec, 2024, 22:20 CST Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global...

10 Dec, 2024, 21:34 CST Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global...

10 Dec, 2024, 21:30 CST Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global...

10 Dec, 2024, 21:27 CST Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global...

10 Dec, 2024, 20:48 CST Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global...

10 Dec, 2024, 08:30 CST Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

10 Dec, 2024, 00:47 CST Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company, today announced that the Australian Human Research Ethics Committees (HREC) have...

09 Dec, 2024, 22:00 CST Seoul National University Bundang Hospital Establishes the first "International PSP Research and Treatment Center" in Korea

Seoul National University Bundang Hospital ("SNUBH"), CurePSP, Inc. ("CurePSP") and GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ: 082270) have announced ...

09 Dec, 2024, 16:42 CST Philips and Singapore General Hospital to advance medical imaging capabilities in Asia Pacific with first-of-its-kind MRI training collaboration

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announces its strategic collaboration with Singapore General Hospital...

09 Dec, 2024, 12:40 CST BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL

A newly published collaborative study[1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology...

09 Dec, 2024, 08:20 CST Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for Advanced Lymphoma at the 66th ASH Annual Meeting

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer...

09 Dec, 2024, 08:00 CST Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

07 Dec, 2024, 11:30 CST EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by...

06 Dec, 2024, 10:41 CST Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations

IMAGINE AI is the largest calendar event in Singapore that brings together the brightest minds in healthcare and artificial intelligence to explore...

06 Dec, 2024, 09:00 CST SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan's RIT/JATA and Korea's International Tuberculosis Research Center

SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced the signing of a tripartite memorandum of understanding...

06 Dec, 2024, 08:07 CST Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence ...

06 Dec, 2024, 06:30 CST 【C.S】 Group Targets Global Pet Medication Market with Groundbreaking Taiwanofungus-Based New Drug

Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S】 Group, Taiwan's largest chain specializing in Taiwanofungus products, has officially announced...

06 Dec, 2024, 06:10 CST KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024

Kaneka Ubiquinol™ has been awarded the coveted Raw Material Supplier of the Year Award 2024 at the Complementary Medicines Australia (CMA) Awards,...

05 Dec, 2024, 22:00 CST AtomVie Global Radiopharma Appoints Dr. Pratibhash Chattopadhyay as Chief Business Officer to Accelerate Growth and Strengthen Leadership

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, is pleased to announce the appointment of Dr. Pratibhash (Bosh)...

05 Dec, 2024, 21:03 CST Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

Field Medical® Inc., a leader in pulsed field cardiac catheter ablation technology, announced today that its FieldForce™ Ablation System has been...

05 Dec, 2024, 18:35 CST Cao Thang International Eye Hospital - Marking a footprint on the map of global ophthalmology

On November 10, 2024, Cao Thang International Eye Hospital was proudly certified to be an official membership with the World Association of Eye...

05 Dec, 2024, 11:59 CST CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, has...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE